Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Elastic NV (ESTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Elastic NV — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.4 (market cap $4.59B), while Elastic NV trades at $95.26 (market cap $10.00B). The key difference: Elastic NV is far larger — about 2.2× Definium Therapeutics Inc. Common Shares's market cap, and Elastic NV is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Elastic NV for 10 Days on average.
| DFTX | ESTC | |
|---|---|---|
Market Cap | $4.59B | $10.00B |
Volume | 2,103,937 | 1,610,337 |
Sector | Health | Technology |
52-Week High | $48.45 | $99.91 |
52-Week Low | $10.68 | $43.30 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $3.55B | $9.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Elastic (ESTC) trades at $93.10, down 1.59% today but maintains strong technical momentum with a bullish moving average signal. The company shows robust revenue growth with Q2 2026 EPS beating expectations at $0.70 versus $0.584, and analyst consensus remains strongly positive with 22 buy ratings and no sell recommendations. Recent product launches including AI-powered metrics and serverless vector database enhancements demonstrate ongoing innovation.
The outlook remains favorable with projected revenue growth to $1.8B in 2026 and net income turning positive to $376M. Key risks include high valuation multiples and competitive pressures in the enterprise software space. The consensus price target of $79.50 suggests potential downside from current levels despite strong fundamentals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Elastic NV
Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.
Read more on ESTC →
